Target intelligence / Profile preview

Viral protein 1 capsid hydrophobic pocket (VP1 pocket)

Target
VP1 pocket
Molecular classification
Viral structural protein
01

Overview

The Viral protein 1 (VP1) capsid hydrophobic pocket is a critical regulatory site located within the structural proteins of viruses in the Picornaviridae family, including human rhinoviruses and enteroviruses (Rossmann et al., 1985, Nature). This pocket is typically occupied by a host-derived fatty acid-like molecule called the pocket factor, which maintains the structural integrity of the viral capsid during transmission (Smith et al., 1986, Science). During the infection process, receptor binding triggers the release of this pocket factor, facilitating the conformational shifts required for the virus to uncoat and inject its RNA into the host cytoplasm (Zhang et al., 2008, PNAS). Small molecule inhibitors, known as capsid binders or WIN compounds, are designed to occupy this pocket with high affinity, thereby stabilizing the capsid and blocking the uncoating step (Pevear et al., 1999, Antimicrob. Agents Chemother.). While drugs like Pleconaril and Pocapavir have targeted this site to treat infections like the common cold and neonatal enteroviral sepsis, the high genetic variability of the VP1 region often leads to the rapid development of resistance (Thibaut et al., 2012, Curr. Opin. Virol.). The pocket's accessibility and conserved role in the viral life cycle make it a primary focus for antiviral drug discovery against picornaviruses.

Other names
VP1 hydrophobic pocketVP1 canyonCapsid-binding pocketWIN pocketVP1 hydrophobic cavity
02

Mechanism of action

Binding to the VP1 hydrophobic pocket stabilizes the viral capsid, preventing the conformational changes required for viral uncoating and genome release into the host cell (Pevear et al., 1999, Antimicrob. Agents Chemother.).

03

Biological functions

Viral entryViral uncoatingCapsid stabilizationGenome release
04

Disease associations

Infection
05

Safety considerations

Rapid emergence of drug-resistant mutations (Thibaut et al., 2012, Curr. Opin. Virol.)Limited cross-serotype efficacy
06

Interacting drugs

Pleconaril

4 more in the full profile.

07

Biomarkers

Viral RNA loadVP1 sequence mutations

Beyond the preview

Go deeper on Viral protein 1 capsid hydrophobic pocket (VP1 pocket).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral protein 1 capsid hydrophobic pocket (VP1 pocket).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call